APO Research
Talk to an analyst

APO RESEARCH · REPORT

Synthetic Peptide Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Research

Synthetic Peptide Vaccine Industry Research Report 2026

29 December 2025131 pages

Choose your research edition.

Industry ResearchSynthetic Peptide Vaccine Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Synthetic Peptide Vaccine Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Synthetic Peptide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Synthetic Peptide Vaccine Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Synthetic Peptide Vaccine Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Synthetic Peptide Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Synthetic Peptide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Synthetic Peptide Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Synthetic Peptide Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Synthetic Peptide Vaccine include Merck, Targovax, TapImmune, Sumitomo Dainippon Pharma, Spotlight Innovation, Pharmasyntez, Peptech, OncoTherapy Science and Lytix Biopharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Synthetic Peptide Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Synthetic Peptide Vaccine Market by Company

Merck

Targovax

TapImmune

Sumitomo Dainippon Pharma

Spotlight Innovation

Pharmasyntez

Peptech

OncoTherapy Science

Lytix Biopharma

ISA Pharmaceuticals

ImmunoCellular Therapeutics

Immatics biotechnologies

Celgene Corporation

Benovus Bio

Artificial Cell Technologies

Apitope Technology

Antigen Express

Anergis

Synthetic Peptide Vaccine Segment by Type

Solution Phase Synthesis (SPS)

Solid Phase Peptide Synthesis (SPPS)

Synthetic Peptide Vaccine Segment by Application

Lung Cancer

Prostate Cancer

Breast Cancer

Gastric Cancer

Pancreatic Cancer

Others

Synthetic Peptide Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Synthetic Peptide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Synthetic Peptide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Synthetic Peptide Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Synthetic Peptide Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Synthetic Peptide Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Synthetic Peptide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Synthetic Peptide Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Synthetic Peptide Vaccine Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Synthetic Peptide Vaccine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Synthetic Peptide Vaccine Revenue of Manufacturers (2021-2026) Table 9. Global Synthetic Peptide Vaccine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Synthetic Peptide Vaccine Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Synthetic Peptide Vaccine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Synthetic Peptide Vaccine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Synthetic Peptide Vaccine, Product Type & Application Table 14. Global Synthetic Peptide Vaccine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Synthetic Peptide Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Merck Company Information Table 19. Merck Business Overview Table 20. Merck Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Merck Synthetic Peptide Vaccine Product Portfolio Table 22. Merck Recent Developments Table 23. Targovax Company Information Table 24. Targovax Business Overview Table 25. Targovax Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Targovax Synthetic Peptide Vaccine Product Portfolio Table 27. Targovax Recent Developments Table 28. TapImmune Company Information Table 29. TapImmune Business Overview Table 30. TapImmune Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. TapImmune Synthetic Peptide Vaccine Product Portfolio Table 32. TapImmune Recent Developments Table 33. Sumitomo Dainippon Pharma Company Information Table 34. Sumitomo Dainippon Pharma Business Overview Table 35. Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Product Portfolio Table 37. Sumitomo Dainippon Pharma Recent Developments Table 38. Spotlight Innovation Company Information Table 39. Spotlight Innovation Business Overview Table 40. Spotlight Innovation Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Spotlight Innovation Synthetic Peptide Vaccine Product Portfolio Table 42. Spotlight Innovation Recent Developments Table 43. Pharmasyntez Company Information Table 44. Pharmasyntez Business Overview Table 45. Pharmasyntez Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Pharmasyntez Synthetic Peptide Vaccine Product Portfolio Table 47. Pharmasyntez Recent Developments Table 48. Peptech Company Information Table 49. Peptech Business Overview Table 50. Peptech Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Peptech Synthetic Peptide Vaccine Product Portfolio Table 52. Peptech Recent Developments Table 53. OncoTherapy Science Company Information Table 54. OncoTherapy Science Business Overview Table 55. OncoTherapy Science Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. OncoTherapy Science Synthetic Peptide Vaccine Product Portfolio Table 57. OncoTherapy Science Recent Developments Table 58. Lytix Biopharma Company Information Table 59. Lytix Biopharma Business Overview Table 60. Lytix Biopharma Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Lytix Biopharma Synthetic Peptide Vaccine Product Portfolio Table 62. Lytix Biopharma Recent Developments Table 63. ISA Pharmaceuticals Company Information Table 64. ISA Pharmaceuticals Business Overview Table 65. ISA Pharmaceuticals Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. ISA Pharmaceuticals Synthetic Peptide Vaccine Product Portfolio Table 67. ISA Pharmaceuticals Recent Developments Table 68. ImmunoCellular Therapeutics Company Information Table 69. ImmunoCellular Therapeutics Business Overview Table 70. ImmunoCellular Therapeutics Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. ImmunoCellular Therapeutics Synthetic Peptide Vaccine Product Portfolio Table 72. ImmunoCellular Therapeutics Recent Developments Table 73. Immatics biotechnologies Company Information Table 74. Immatics biotechnologies Business Overview Table 75. Immatics biotechnologies Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Immatics biotechnologies Synthetic Peptide Vaccine Product Portfolio Table 77. Immatics biotechnologies Recent Developments Table 78. Celgene Corporation Company Information Table 79. Celgene Corporation Business Overview Table 80. Celgene Corporation Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Celgene Corporation Synthetic Peptide Vaccine Product Portfolio Table 82. Celgene Corporation Recent Developments Table 83. Benovus Bio Company Information Table 84. Benovus Bio Business Overview Table 85. Benovus Bio Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Benovus Bio Synthetic Peptide Vaccine Product Portfolio Table 87. Benovus Bio Recent Developments Table 88. Artificial Cell Technologies Company Information Table 89. Artificial Cell Technologies Business Overview Table 90. Artificial Cell Technologies Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Artificial Cell Technologies Synthetic Peptide Vaccine Product Portfolio Table 92. Artificial Cell Technologies Recent Developments Table 93. Apitope Technology Company Information Table 94. Apitope Technology Business Overview Table 95. Apitope Technology Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Apitope Technology Synthetic Peptide Vaccine Product Portfolio Table 97. Apitope Technology Recent Developments Table 98. Antigen Express Company Information Table 99. Antigen Express Business Overview Table 100. Antigen Express Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Antigen Express Synthetic Peptide Vaccine Product Portfolio Table 102. Antigen Express Recent Developments Table 103. Anergis Company Information Table 104. Anergis Business Overview Table 105. Anergis Synthetic Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Anergis Synthetic Peptide Vaccine Product Portfolio Table 107. Anergis Recent Developments Table 108. Global Synthetic Peptide Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Synthetic Peptide Vaccine Sales by Region (2021-2026) & (K Units) Table 110. Global Synthetic Peptide Vaccine Sales Market Share by Region (2021-2026) Table 111. Global Synthetic Peptide Vaccine Sales by Region (2027-2032) & (K Units) Table 112. Global Synthetic Peptide Vaccine Sales Market Share by Region (2027-2032) Table 113. Global Synthetic Peptide Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2021-2026) Table 115. Global Synthetic Peptide Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2027-2032) Table 117. North America Synthetic Peptide Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Synthetic Peptide Vaccine Sales by Country (2021-2026) & (K Units) Table 119. North America Synthetic Peptide Vaccine Sales by Country (2027-2032) & (K Units) Table 120. North America Synthetic Peptide Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Synthetic Peptide Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Synthetic Peptide Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Synthetic Peptide Vaccine Sales by Country (2021-2026) & (K Units) Table 124. Europe Synthetic Peptide Vaccine Sales by Country (2027-2032) & (K Units) Table 125. Europe Synthetic Peptide Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Synthetic Peptide Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Synthetic Peptide Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Synthetic Peptide Vaccine Sales by Country (2021-2026) & (K Units) Table 129. Asia Pacific Synthetic Peptide Vaccine Sales by Country (2027-2032) & (K Units) Table 130. Asia Pacific Synthetic Peptide Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Synthetic Peptide Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Synthetic Peptide Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Synthetic Peptide Vaccine Sales by Country (2021-2026) & (K Units) Table 134. South America Synthetic Peptide Vaccine Sales by Country (2027-2032) & (K Units) Table 135. South America Synthetic Peptide Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Synthetic Peptide Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Synthetic Peptide Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Synthetic Peptide Vaccine Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Synthetic Peptide Vaccine Sales by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Synthetic Peptide Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Synthetic Peptide Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Synthetic Peptide Vaccine Sales by Type (2021-2026) & (K Units) Table 143. Global Synthetic Peptide Vaccine Sales by Type (2027-2032) & (K Units) Table 144. Global Synthetic Peptide Vaccine Sales Market Share by Type (2021-2026) Table 145. Global Synthetic Peptide Vaccine Sales Market Share by Type (2027-2032) Table 146. Global Synthetic Peptide Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Synthetic Peptide Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Synthetic Peptide Vaccine Revenue Market Share by Type (2021-2026) Table 149. Global Synthetic Peptide Vaccine Revenue Market Share by Type (2027-2032) Table 150. Global Synthetic Peptide Vaccine Price by Type (2021-2026) & (US$/Unit) Table 151. Global Synthetic Peptide Vaccine Price by Type (2027-2032) & (US$/Unit) Table 152. Global Synthetic Peptide Vaccine Sales by Application (2021-2026) & (K Units) Table 153. Global Synthetic Peptide Vaccine Sales by Application (2027-2032) & (K Units) Table 154. Global Synthetic Peptide Vaccine Sales Market Share by Application (2021-2026) Table 155. Global Synthetic Peptide Vaccine Sales Market Share by Application (2027-2032) Table 156. Global Synthetic Peptide Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Synthetic Peptide Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Synthetic Peptide Vaccine Revenue Market Share by Application (2021-2026) Table 159. Global Synthetic Peptide Vaccine Revenue Market Share by Application (2027-2032) Table 160. Global Synthetic Peptide Vaccine Price by Application (2021-2026) & (US$/Unit) Table 161. Global Synthetic Peptide Vaccine Price by Application (2027-2032) & (US$/Unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Synthetic Peptide Vaccine Distributors List Table 165. Synthetic Peptide Vaccine Customers List Table 166. Synthetic Peptide Vaccine Industry Trends Table 167. Synthetic Peptide Vaccine Industry Drivers Table 168. Synthetic Peptide Vaccine Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Synthetic Peptide Vaccine Product Image Figure 5. Global Synthetic Peptide Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Synthetic Peptide Vaccine Market Size (2021-2032) & (US$ Million) Figure 7. Global Synthetic Peptide Vaccine Sales (2021-2032) & (K Units) Figure 8. Global Synthetic Peptide Vaccine Average Price (US$/Unit) & (2021-2032) Figure 9. Solution Phase Synthesis (SPS) Product Image Figure 10. Solid Phase Peptide Synthesis (SPPS) Product Image Figure 11. Lung Cancer Product Image Figure 12. Prostate Cancer Product Image Figure 13. Breast Cancer Product Image Figure 14. Gastric Cancer Product Image Figure 15. Pancreatic Cancer Product Image Figure 16. Others Product Image Figure 17. Global Synthetic Peptide Vaccine Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Synthetic Peptide Vaccine, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Synthetic Peptide Vaccine Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Synthetic Peptide Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Synthetic Peptide Vaccine Sales by Region in 2025 Figure 23. Global Synthetic Peptide Vaccine Revenue by Region in 2025 Figure 24. North America Synthetic Peptide Vaccine Market Size by Country in 2025 Figure 25. North America Synthetic Peptide Vaccine Sales Market Share by Country (2021-2032) Figure 26. North America Synthetic Peptide Vaccine Revenue Market Share by Country (2021-2032) Figure 27. United States Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Synthetic Peptide Vaccine Market Size by Country in 2025 Figure 30. Europe Synthetic Peptide Vaccine Sales Market Share by Country (2021-2032) Figure 31. Europe Synthetic Peptide Vaccine Revenue Market Share by Country (2021-2032) Figure 32. Germany Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Asia Pacific Synthetic Peptide Vaccine Market Size by Country in 2025 Figure 38. Asia Pacific Synthetic Peptide Vaccine Sales Market Share by Country (2021-2032) Figure 39. Asia Pacific Synthetic Peptide Vaccine Revenue Market Share by Country (2021-2032) Figure 40. China Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Japan Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. South Korea Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. India Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Australia Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. China Taiwan Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Southeast Asia Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South America Synthetic Peptide Vaccine Market Size by Country in 2025 Figure 49. South America Synthetic Peptide Vaccine Sales Market Share by Country (2021-2032) Figure 50. South America Synthetic Peptide Vaccine Revenue Market Share by Country (2021-2032) Figure 51. Mexico Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Brazil Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Argentina Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Middle East and Africa Synthetic Peptide Vaccine Market Size by Country in 2025 Figure 55. Middle East and Africa Synthetic Peptide Vaccine Sales Market Share by Country (2021-2032) Figure 56. Middle East and Africa Synthetic Peptide Vaccine Revenue Market Share by Country (2021-2032) Figure 57. Turkey Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. UAE Synthetic Peptide Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Global Synthetic Peptide Vaccine Sales Market Share by Type (2021-2032) Figure 61. Global Synthetic Peptide Vaccine Revenue Market Share by Type (2021-2032) Figure 62. Global Synthetic Peptide Vaccine Price (US$/Unit) by Type (2021-2032) Figure 63. Global Synthetic Peptide Vaccine Sales Market Share by Application (2021-2032) Figure 64. Global Synthetic Peptide Vaccine Revenue Market Share by Application (2021-2032) Figure 65. Global Synthetic Peptide Vaccine Price (US$/Unit) by Application (2021-2032) Figure 66. Synthetic Peptide Vaccine Value Chain Figure 67. Synthetic Peptide Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Synthetic Peptide Vaccine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Solution Phase Synthesis (SPS)
  • Solid Phase Peptide Synthesis (SPPS)
Applications
  • Lung Cancer
  • Prostate Cancer
  • Breast Cancer
  • Gastric Cancer
  • Pancreatic Cancer
  • Others
Companies covered
  • Merck
  • Targovax
  • TapImmune
  • Sumitomo Dainippon Pharma
  • Spotlight Innovation
  • Pharmasyntez
  • Peptech
  • OncoTherapy Science
  • Lytix Biopharma
  • ISA Pharmaceuticals
  • ImmunoCellular Therapeutics
  • Immatics biotechnologies
  • Celgene Corporation
  • Benovus Bio
  • Artificial Cell Technologies
  • Apitope Technology
  • Antigen Express
  • Anergis

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Synthetic Peptide Vaccine Market Size (2021-2032)
  4. 2.2.2 Global Synthetic Peptide Vaccine Sales (2021-2032)
  5. 2.2.3 Global Synthetic Peptide Vaccine Market Average Price (2021-2032)
  6. 2.3 Synthetic Peptide Vaccine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Solution Phase Synthesis (SPS)
  9. 2.3.3 Solid Phase Peptide Synthesis (SPPS)
  10. 2.4 Synthetic Peptide Vaccine by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Lung Cancer
  13. 2.4.3 Prostate Cancer
  14. 2.4.4 Breast Cancer
  15. 2.4.5 Gastric Cancer
  16. 2.4.6 Pancreatic Cancer
  17. 2.4.7 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Synthetic Peptide Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Synthetic Peptide Vaccine Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Synthetic Peptide Vaccine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Synthetic Peptide Vaccine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Synthetic Peptide Vaccine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Synthetic Peptide Vaccine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Synthetic Peptide Vaccine, Product Type & Application
  8. 3.8 Global Manufacturers of Synthetic Peptide Vaccine, Established Date
  9. 3.9 Global Synthetic Peptide Vaccine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Merck
  2. 4.1.1 Merck Company Information
  3. 4.1.2 Merck Business Overview
  4. 4.1.3 Merck Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Merck Synthetic Peptide Vaccine Product Portfolio
  6. 4.1.5 Merck Recent Developments
  7. 4.2 Targovax
  8. 4.2.1 Targovax Company Information
  9. 4.2.2 Targovax Business Overview
  10. 4.2.3 Targovax Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Targovax Synthetic Peptide Vaccine Product Portfolio
  12. 4.2.5 Targovax Recent Developments
  13. 4.3 TapImmune
  14. 4.3.1 TapImmune Company Information
  15. 4.3.2 TapImmune Business Overview
  16. 4.3.3 TapImmune Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 TapImmune Synthetic Peptide Vaccine Product Portfolio
  18. 4.3.5 TapImmune Recent Developments
  19. 4.4 Sumitomo Dainippon Pharma
  20. 4.4.1 Sumitomo Dainippon Pharma Company Information
  21. 4.4.2 Sumitomo Dainippon Pharma Business Overview
  22. 4.4.3 Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Sumitomo Dainippon Pharma Synthetic Peptide Vaccine Product Portfolio
  24. 4.4.5 Sumitomo Dainippon Pharma Recent Developments
  25. 4.5 Spotlight Innovation
  26. 4.5.1 Spotlight Innovation Company Information
  27. 4.5.2 Spotlight Innovation Business Overview
  28. 4.5.3 Spotlight Innovation Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Spotlight Innovation Synthetic Peptide Vaccine Product Portfolio
  30. 4.5.5 Spotlight Innovation Recent Developments
  31. 4.6 Pharmasyntez
  32. 4.6.1 Pharmasyntez Company Information
  33. 4.6.2 Pharmasyntez Business Overview
  34. 4.6.3 Pharmasyntez Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Pharmasyntez Synthetic Peptide Vaccine Product Portfolio
  36. 4.6.5 Pharmasyntez Recent Developments
  37. 4.7 Peptech
  38. 4.7.1 Peptech Company Information
  39. 4.7.2 Peptech Business Overview
  40. 4.7.3 Peptech Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Peptech Synthetic Peptide Vaccine Product Portfolio
  42. 4.7.5 Peptech Recent Developments
  43. 4.8 OncoTherapy Science
  44. 4.8.1 OncoTherapy Science Company Information
  45. 4.8.2 OncoTherapy Science Business Overview
  46. 4.8.3 OncoTherapy Science Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 OncoTherapy Science Synthetic Peptide Vaccine Product Portfolio
  48. 4.8.5 OncoTherapy Science Recent Developments
  49. 4.9 Lytix Biopharma
  50. 4.9.1 Lytix Biopharma Company Information
  51. 4.9.2 Lytix Biopharma Business Overview
  52. 4.9.3 Lytix Biopharma Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Lytix Biopharma Synthetic Peptide Vaccine Product Portfolio
  54. 4.9.5 Lytix Biopharma Recent Developments
  55. 4.10 ISA Pharmaceuticals
  56. 4.10.1 ISA Pharmaceuticals Company Information
  57. 4.10.2 ISA Pharmaceuticals Business Overview
  58. 4.10.3 ISA Pharmaceuticals Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 ISA Pharmaceuticals Synthetic Peptide Vaccine Product Portfolio
  60. 4.10.5 ISA Pharmaceuticals Recent Developments
  61. 4.11 ImmunoCellular Therapeutics
  62. 4.11.1 ImmunoCellular Therapeutics Company Information
  63. 4.11.2 ImmunoCellular Therapeutics Business Overview
  64. 4.11.3 ImmunoCellular Therapeutics Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 ImmunoCellular Therapeutics Synthetic Peptide Vaccine Product Portfolio
  66. 4.11.5 ImmunoCellular Therapeutics Recent Developments
  67. 4.12 Immatics biotechnologies
  68. 4.12.1 Immatics biotechnologies Company Information
  69. 4.12.2 Immatics biotechnologies Business Overview
  70. 4.12.3 Immatics biotechnologies Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Immatics biotechnologies Synthetic Peptide Vaccine Product Portfolio
  72. 4.12.5 Immatics biotechnologies Recent Developments
  73. 4.13 Celgene Corporation
  74. 4.13.1 Celgene Corporation Company Information
  75. 4.13.2 Celgene Corporation Business Overview
  76. 4.13.3 Celgene Corporation Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Celgene Corporation Synthetic Peptide Vaccine Product Portfolio
  78. 4.13.5 Celgene Corporation Recent Developments
  79. 4.14 Benovus Bio
  80. 4.14.1 Benovus Bio Company Information
  81. 4.14.2 Benovus Bio Business Overview
  82. 4.14.3 Benovus Bio Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Benovus Bio Synthetic Peptide Vaccine Product Portfolio
  84. 4.14.5 Benovus Bio Recent Developments
  85. 4.15 Artificial Cell Technologies
  86. 4.15.1 Artificial Cell Technologies Company Information
  87. 4.15.2 Artificial Cell Technologies Business Overview
  88. 4.15.3 Artificial Cell Technologies Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Artificial Cell Technologies Synthetic Peptide Vaccine Product Portfolio
  90. 4.15.5 Artificial Cell Technologies Recent Developments
  91. 4.16 Apitope Technology
  92. 4.16.1 Apitope Technology Company Information
  93. 4.16.2 Apitope Technology Business Overview
  94. 4.16.3 Apitope Technology Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Apitope Technology Synthetic Peptide Vaccine Product Portfolio
  96. 4.16.5 Apitope Technology Recent Developments
  97. 4.17 Antigen Express
  98. 4.17.1 Antigen Express Company Information
  99. 4.17.2 Antigen Express Business Overview
  100. 4.17.3 Antigen Express Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Antigen Express Synthetic Peptide Vaccine Product Portfolio
  102. 4.17.5 Antigen Express Recent Developments
  103. 4.18 Anergis
  104. 4.18.1 Anergis Company Information
  105. 4.18.2 Anergis Business Overview
  106. 4.18.3 Anergis Synthetic Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Anergis Synthetic Peptide Vaccine Product Portfolio
  108. 4.18.5 Anergis Recent Developments
5 Global Synthetic Peptide Vaccine Market Scenario by Region
  1. 5.1 Global Synthetic Peptide Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Synthetic Peptide Vaccine Sales by Region: 2021-2032
  3. 5.2.1 Global Synthetic Peptide Vaccine Sales by Region: 2021-2026
  4. 5.2.2 Global Synthetic Peptide Vaccine Sales by Region: 2027-2032
  5. 5.3 Global Synthetic Peptide Vaccine Revenue by Region: 2021-2032
  6. 5.3.1 Global Synthetic Peptide Vaccine Revenue by Region: 2021-2026
  7. 5.3.2 Global Synthetic Peptide Vaccine Revenue by Region: 2027-2032
  8. 5.4 North America Synthetic Peptide Vaccine Market Facts & Figures by Country
  9. 5.4.1 North America Synthetic Peptide Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Synthetic Peptide Vaccine Sales by Country (2021-2032)
  11. 5.4.3 North America Synthetic Peptide Vaccine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Synthetic Peptide Vaccine Market Facts & Figures by Country
  15. 5.5.1 Europe Synthetic Peptide Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Synthetic Peptide Vaccine Sales by Country (2021-2032)
  17. 5.5.3 Europe Synthetic Peptide Vaccine Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Synthetic Peptide Vaccine Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Synthetic Peptide Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Synthetic Peptide Vaccine Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Synthetic Peptide Vaccine Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Synthetic Peptide Vaccine Market Facts & Figures by Country
  35. 5.7.1 South America Synthetic Peptide Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Synthetic Peptide Vaccine Sales by Country (2021-2032)
  37. 5.7.3 South America Synthetic Peptide Vaccine Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Synthetic Peptide Vaccine Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Synthetic Peptide Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Synthetic Peptide Vaccine Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Synthetic Peptide Vaccine Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Synthetic Peptide Vaccine Sales by Type (2021-2032)
  2. 6.1.1 Global Synthetic Peptide Vaccine Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Synthetic Peptide Vaccine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Synthetic Peptide Vaccine Revenue by Type (2021-2032)
  5. 6.2.1 Global Synthetic Peptide Vaccine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Synthetic Peptide Vaccine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Synthetic Peptide Vaccine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Synthetic Peptide Vaccine Sales by Application (2021-2032)
  2. 7.1.1 Global Synthetic Peptide Vaccine Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Synthetic Peptide Vaccine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Synthetic Peptide Vaccine Revenue by Application (2021-2032)
  5. 7.2.1 Global Synthetic Peptide Vaccine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Synthetic Peptide Vaccine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Synthetic Peptide Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Synthetic Peptide Vaccine Value Chain Analysis
  2. 8.1.1 Synthetic Peptide Vaccine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Synthetic Peptide Vaccine Production Mode & Process
  5. 8.2 Synthetic Peptide Vaccine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Synthetic Peptide Vaccine Distributors
  8. 8.2.3 Synthetic Peptide Vaccine Customers
9 Global Synthetic Peptide Vaccine Analyzing Market Dynamics
  1. 9.1 Synthetic Peptide Vaccine Industry Trends
  2. 9.2 Synthetic Peptide Vaccine Industry Drivers
  3. 9.3 Synthetic Peptide Vaccine Industry Opportunities and Challenges
  4. 9.4 Synthetic Peptide Vaccine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst